Terminally Ill Access to Treatment Act of 1996

Summary

Terminally Ill Access to Treatment Act of 1996 - Directs the Secretary of Health and Human Services to approve, for treating the terminally ill only, drugs and devices that have not received final approval from the Food and Drug Administration (FDA) and that have not been shown to be unsafe. Declares that it is not illegal for a health care practitioner to administer a drug or device approved under this Act to a terminally ill patient if the practitioner has notified the patient that the drug or device is not FDA-approved and is experimental and if the practitioner has received written approval from the patient or the patient's representative. Requires a practitioner to report acute harm done by such a drug or device. Requires the Secretary to give public notice of the benefits and harm caused by such a drug or device.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 21 March 1996

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 21 March 1996

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 21 March 1996

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.